Gradelski Elizabeth, Kolek Benjamin, Bonner Daniel, Fung-Tomc Joan
Department of Microbiology, Bristol-Myers Squibb Company, Wallingford, CT 06492, USA.
J Antimicrob Chemother. 2002 Jan;49(1):185-8. doi: 10.1093/jac/49.1.185.
The quinolones differ in their mechanisms of bacterial killing. The rate of bacterial killing by quinolones can be influenced by the addition of bacterial protein or RNA synthesis inhibitors, and the growth phase of the bacterium. In this study, we compared the killing activities of gatifloxacin, trovafloxacin, ciprofloxacin and norfloxacin against staphylococci, pneumococci and Escherichia coli. Gatifloxacin killing of these organisms occurred regardless of the metabolic state of the microbes. Unlike the comparator quinolones, gatifloxacin killing was not influenced by the addition of bacterial protein or RNA synthesis inhibitors. Gatifloxacin was able to kill non-dividing staphylococcal and E. coli cells.
喹诺酮类药物在细菌杀伤机制上存在差异。喹诺酮类药物的细菌杀伤速率会受到细菌蛋白质或RNA合成抑制剂的添加以及细菌生长阶段的影响。在本研究中,我们比较了加替沙星、曲伐沙星、环丙沙星和诺氟沙星对葡萄球菌、肺炎球菌和大肠杆菌的杀伤活性。加替沙星对这些微生物的杀伤作用不受微生物代谢状态的影响。与对照喹诺酮类药物不同,加替沙星的杀伤作用不受细菌蛋白质或RNA合成抑制剂添加的影响。加替沙星能够杀死不分裂的葡萄球菌和大肠杆菌细胞。